CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

Posts Tagged ‘ROCKET AF’

April 9th, 2015

Digoxin Use in Afib: Revisiting Data from ROCKET AF

Manesh R. Patel discusses his research group’s retrospective analysis of data on digoxin use among patients with atrial fibrillation in the ROCKET AF trial.

Categories: Electrophysiology
Tags: , , ,

February 24th, 2014

What Is “Non-Valvular” Atrial Fibrillation?

Wes Fisher attempts to figure out what the latest marketing phrase – non-valvular atrial fibrillation – really means.

Categories: Anticoagulation, General
Tags: , , , ,

January 17th, 2013

Revisiting Novel Anticoagulants in Atrial Fibrillation

and

Two experts discuss the evolving landscape of novel anticoagulants for patients with AF. Do you agree with their perspectives? What questions do you have? What has your experience taught you?

Categories: Anticoagulation, Electrophysiology, General
Tags: , , , , , , , ,

October 6th, 2011

Rivaroxaban Roundup: ATLAS-ACS an AHA Late-Breaker, NEJM Perspective, NYT Overview

Rivaroxaban (Xarelto, Bayer and Johnson & Johnson) is in the news today. In a rare move, the AHA has added the ATLAS ACS 2-TIMI 51 trial to its roster of Late-Breaking Clinical Trials to be presented next month at the AHA’s Scientific Sessions in Orlando. C. Michael Gibson will present the results on Sunday, November 13, at 5:13 PM. Last week, Bayer […]

Categories: Anticoagulation
Tags: , ,